- Патологія еклампсії: серія розтинів
Патологія еклампсії: серія розтинів
HEALTH OF WOMAN. 2017.6(122):152–157
Jonathan L. Hecht, Jaume Ordi, Carla Carrilho, Mamudo R. Ismail, Zsuzsanna K. Zsengeller, S. Ananth Karumanchi, and Seymour Rosen
Скорочений варіант. Адаптовано – С.О. Шурпяк
Литература
1. Duley L. The Global Impact of Pre-Eclampsia and Eclampsia, Semin. Perinatol. 2009:33:130–137. https://doi.org/10.1053/j.semperi.2009.02.010; PMid:19464502
2. Powe CE, Levine RJ, and Karumanchi SA. Preeclampsia, A Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease, Circulation. 2011:123:2856–2869. https://doi.org/10.1161/CIRCULATIONAHA.109.853127; PMid:21690502 PMCid:PMC3148781
3. Hod T, Cerdeira AS, and Karumanchi SA. Molecular Mechanisms of Preeclampsia, Cold Spring Harbor Perspect. Med. 2015;5:a023473. ?
4. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, and Group CS. Soluble Endoglin and other Circulating Antiangiogenic Factors in Preeclampsia, N. Engl. J. Med. 2006: 355: 992–1005. https://doi.org/10.1056/NEJMoa055352; PMid:16957146
5. Vaisbuch E, Whitty JE, Hassan SS, Romero R, Kusanovic JP, Cotton DB, Sorokin Y, and Karumanchi SA. Circulating Angiogenic and Antiangiogenic Factors in Women with Eclampsia, Am. J. Obstetrics Gynecol. 2011: 204: 152 e1–e9.
6. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D’Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M,and Karumanchi SA. Soluble Endoglin Contributes to the Pathogenesis of Preeclampsia, Nat. Med. 2006: 12:642–649. https://doi.org/10.1038/nm0706-862c; https://doi.org/10.1038/nm1429; PMid:16751767
7. Roberts JM and Hubel CA. Oxidative Stress in Preeclampsia, Am. J. Obstetrics Gynecol. 2004:190: 1177–1178. https://doi.org/10.1016/j.ajog.2004.04.001; PMid:15167813
8. Sheehan HL and Lynch JB. Pathology of Toxaemia of Pregnancy. Williams and Wilkins Company, Baltimore, 1973.
9. Menendez C, Romagosa C, Ismail MR, Carrilho C, Saute F, Osman N, Machungo F, Bardaji A, Quinto L, Mayor A, Naniche D, Dobano C, Alonso PL, and Ordi J. An Autopsy Study of Maternal Mortality in Mozambique: The Contribution of Infectious Diseases, PLoS Med. 2008:5:e44. https://doi.org/10.1371/journal.pmed.0050044; PMid:18288887 PMCid:PMC2245982
10. Hecht JL, Zsengeller ZK, Spiel M, Karumanchi SA, and Rosen S. Revisiting Decidual Vasculopathy, Placenta. 2016:42:37–43. https://doi.org/10.1016/j.placenta.2016.04.006; PMid:27238712
11. Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM, Bravo SM, Klufas RA, Chai RY, and Repke JT. Preeclampsia-Eclampsia: Clinical and Neuroradiographic Correlates and Insights into the Pathogenesis of Hypertensive Encephalopathy, Radiology. 2000:217:371–376. https://doi.org/10.1148/radiology.217.2.r00nv44371; PMid:11058630
12. Stillman IE and Karumanchi SA. The Glomerular Injury of Preeclampsia, J. Am. Soc. Nephrol.: JASN. 2007:18:2281–2284. https://doi.org/10.1681/ASN.2007020255; PMid:17634433
13. Antia FP, Bharadwaj TP, Watsa MC and Master J. Liver in Normal Pregnancy, Pre-eclampsia, and Eclampsia, Lancet. 1958:2:776–778. https://doi.org/10.1016/S0140-6736(58)91481-8
14. Tsokos M, Longauer F, Kardosova V, Gavel A, Anders S, and Schulz F. Maternal Death in Pregnancy from HELLP Syndrome. A Report of Three Medico-Legal Autopsy Cases with Special Reference to Distinctive Histopathological Alterations, Int. J. Legal Med. 2002:116:50–53. https://doi.org/10.1007/s00414-001-0276-5; PMid:11924711
15. Long RG, Scheuer PJ, and Sherlock S. Pre-Eclampsia Presenting with Deep Jaundice, J. Clin. Pathol. 1977:30:212–215. https://doi.org/10.1136/jcp.30.3.212
16. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, and Karumanchi SA. Excess Placental Soluble Fms-Like Tyrosine Kinase 1 (sFlt1) May Contribute to Endothelial Dysfunction, Hypertension, and Proteinuria in Preeclampsia, J. Clin. Invest. 2003:111:649–658.
17. McCarthy FP, Kingdom JC, Kenny LC, and Walsh SK. Animal Models of Preeclampsia; Uses and Limitations, Placenta. 2011:32:413–419. https://doi.org/10.1172/JCI17189; PMid:12618519 PMCid:PMC151901
18. Mahasreshti PJ, Kataram M, Wang MH, Stockard CR, Grizzle WE, Carey D, Siegal GP, Haisma HJ, Alvarez RD, and Curiel DT. Intravenous Delivery of Adenovirus-Mediated Soluble FLT-1 Results in Liver Toxicity, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 2003:9:2701–2710.
19. Abildgaard U and Heimdal K. Pathogenesis of the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count (HELLP): A Review, Eur. J. Obstet. Gynecol. Reprod. Biol. 2013:166:117–123. https://doi.org/10.1016/j.ejogrb.2012.09.026; PMid:23107053
20. Govan AD. The Histology of Eclamptic Lesions, J. Clin. Pathol. Suppl. 1976:10:63–69. https://doi.org/10.1136/jcp.29.Suppl_10.63; https://doi.org/10.1136/jcp.s3-10.1.63
21. Iwakiri Y, Shah V, and Rockey DC. Vascular Pathobiology in Chronic Liver Disease and Cirrhosis – Current Status and Future Directions. J. Hepatol. 2014:61:912–924. https://doi.org/10.1016/j.jhep.2014.05.047; PMid:24911462 PMCid:PMC4346093
22. Lazarus A and Keshet E. Vascular Endothelial Growth Factor and Vascular Homeostasis, Proc. Am. Thoracic Soc. 2011:8:508–511. https://doi.org/10.1513/pats.201102-021MW; PMid:22052928
23. Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, and D’Amore PA. VEGF and TGF-beta are Required for the Maintenance of the Choroid Plexus and Ependyma, J. Exp. Med. 2008:205:491–501. https://doi.org/10.1084/jem.20072041; PMid:18268040 PMCid:PMC2271023
24. Brown LF, Berse B, Tognazzi K, Manseau EJ, Van de Water L, Senger DR, Dvorak HF, and Rosen S. Vascular Permeability Factor mRNA and Protein Expression in Human Kidney, Kidney Int. 1992:42:1457–1461. https://doi.org/10.1038/ki.1992.441; PMid:1474780